共 185 条
[1]
Modlin I.M.(2006)Therapeutic options for gastrointestinal carcinoids Clin Gastroenterol Hepatol 4 526-547
[2]
Latich I.(2006)Quality of life in acromegaly Neuroendocrinology 83 224-229
[3]
Kidd M.(2009)Guidelines for acromegaly management: an update J Clin Endocrinol Metab 94 1509-1517
[4]
Zikusoka M.(2010)Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours Acta Oncol 49 740-756
[5]
Eick G.(2009)From somatostatin to octreotide LAR: evolution of a somatostatin analogue Curr Med Res Opin 25 2989-2999
[6]
Webb S.M.(1982)SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action Life Sci 31 1133-1140
[7]
Melmed S.(2005)Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumors Mayo Clin Proc 80 502-506
[8]
Colao A.(2008)Pasireotide (SOM230): development, mechanism of action and potential applications Mol Cell Endocrinol 286 69-74
[9]
Barkan A.(2005)Consensus statement: medical management of acromegaly Eur J Endocrinol 153 737-740
[10]
Janson E.T.(2004)Neuroendocrine tumors Ann Oncol 15 iv293-iv2989